Primary brain tumor
Conditions
Interventions
Intravenous injection of 18F-FLT PET imaging
Sponsors
Institute of Biomedical Research and Innovation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects who were clinically diagnosed with primary glioma derived brain parenchyma Over 30 years old Subjects who the informed consent was obtained Subjects Who is a health problem to participate in clinical research
Exclusion criteria
Exclusion criteria: Subjects who consciousness is not clear Subjects with cerebrovascular disorder Subjects with cardiac dysfunction Subjects with high degree of arrhythmia Subjects with liver and kidney failure Subjects with serious lung disease, bronchial asthma and endocrine disease Subjects who can not lay in the supine position during about 30 minutes for the pain Subjects who is extreme claustrophobia Pregnants or Subjects who have a possibility of pregnancy Subjects who have the history of drug allergy Subjects who are dehydration and malnutrition state Subjects who are drug dependence, alcohol dependence Subjects who reserchers judged as inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Integrated ratio of the lesion and the normal portion | — |
Secondary
| Measure | Time frame |
|---|---|
| Standard uptake value(SUV) of the striatum | — |
Countries
Japan
Contacts
Public ContactAkihito Ohnishi
Institute of Biomedical Research and Innovation Division of Molecular Imaging
Outcome results
None listed